![]() |
|||
![]() |

A major question in cell
biology is how molecular specificity is achieved by different growth factor
receptors that activate apparently identical signaling events. For the neurotrophin family, a distinguishing feature is the
ability to maintain a prolonged duration of signal transduction. However, the
mechanisms by which neurotrophin receptors assemble
such a sustained signaling complex are not understood. Here we report that an
unusual ankyrin-rich transmembrane
protein (ARMS+kidins220) is closely associated with Trk
receptor tyrosine kinases, and not the EGF receptor.
This association requires interactions between transmembrane
domains of Trk and ARMS. ARMS is rapidly tyrosine phosphorylated after binding of neurotrophins
to Trk receptors and provides a docking site for the
CrkL-C3G complex, resulting in Rap1-dependent sustained ERK activation.
Accordingly, disruption of Trk-ARMS or the ARMS-CrkL interaction with dominant-negative ARMS mutants, or
treatment with small interference RNA against ARMS substantially reduce neurotrophin-elicited signaling to ERK, but without any
effect upon Ras or Akt
activation. These findings suggest that ARMS acts as a major and
neuronal-specific platform for prolonged MAP kinase
signaling by neurotrophins
Phospholipase Cepsilon
(PLCepsilon) is a novel PLC that has a CDC25 guanine
nucleotide exchange factor (GEF) domain and two Ras
association (RA) domains of which the second (RA2) is critical for Ras activation of the enzyme. In the present studies, we
examined hormonal stimulation to elucidate receptor-mediated pathways that
functionally regulate PLCepsilon. We demonstrate that
epidermal growth factor (EGF), a receptor tyrosine kinase
(RTK) agonist, and lysophosphatidic acid (LPA),
sphingosine-1-phosphate (S1P), and thrombin, G protein-coupled receptor
agonists, stimulate PLCepsilon overexpressed
in COS-7 cells. EGF stimulated PLCepsilon in an
RA2-dependent manner through Ras and Rap. In
contrast, LPA, S1P and thrombin stimulated PLCepsilon
by both RA2-independent and dependent mechanisms. To determine the G proteins
that mediate the effects of these GPCR agonists, we coexpressed
constitutively active G proteins with PLCepsilon and
found that Galpha12, Galpha13,